Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
Amy Allen Whitfield, Director of Alternate Site Infusion at Takeda, shared Takeda‘s post on LinkedIn:
“One of the most inspiring aspects of the bleeding disorders community is its commitment to working together.
Collaboration like this helps create meaningful impact across the community.”
Takeda shared a post on LinkedIn:
“The bleeding disorders community never fails to inspire – and this year’s National Bleeding Disorders Foundation (NBDF) Conference was no exception.
Our team was on the ground connecting with patients, caregivers, advocates, clinicians and industry experts, who inspire progress and hope across the bleeding disorders community.
Conversations touched on the lived experiences and everyday realities of living with a bleeding disorder.
What stood out most to our team was the camaraderie across the community that’s been built over years of showing up, listening and working together to overcome barriers to care.
That connection shapes how we innovate and support this community.
Grateful to everyone who stopped by and engaged with us as we continue to help move bleeding disorders care forward.”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 12:57David McIntosh: Why Do Blood Supplies Still Fall Short?
-
Aug 21, 2026, 12:48Joshua Penrod: 35 Years of Progress in Plasma Safety
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency
-
Aug 21, 2026, 12:38Luluva Ghadiyali: Modern Approaches to Aplastic Anemia
-
Aug 21, 2026, 12:34Kellie Machlus: Animal Models Driving Progress in Thrombosis Research
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?